Artificial Intelligence
ChatGPT shows promise for answering questions related to retinal diseases
AI showed favorable results in generating accurate responses to multiple questions covering diagnostic criteria, treatment guidelines and management strategies for retinal diseases.
FDA clears upgraded AI for detection, scoring of coronary calcium
Nanox announced its subsidiary, Nanox.AI, received FDA 510(k) clearance for its AI-powered coronary artery disease detection solution.
AI-based GI Genius boosts adenoma, sessile serrated lesion detection vs. colonoscopy alone
An AI-assisted endoscopy module increased adenoma detection, including sessile serrated lesions, during colonoscopy and is recommended in routine practice to reduce incidence of post-procedure colorectal cancer, according to researchers.
VIDEO: Eye6 smart glasses improve vision in patients with AMD
CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Kelley Sheets of Eyedaptic gives an overview of the Eye6 wearable vision aid for patients with age-related macular degeneration.
AI may help create scientific abstracts
Large language models may be helpful in generating scientific abstracts, according to research presented at the American Society of Retina Specialists annual meeting.
ASCO principles designed to guide development, ’responsible use’ of AI in oncology
During a shareholder presentation in front of more than 500 physicians in April, Debra A. Patt, MD, PhD, MBA, FASCO, asked how many in attendance used large language models like ChatGPT and Claude.
‘Era of AI is here,’ but not yet reducing physician burnout
Rapidly advancing technology in artificial intelligence and other spaces has yet to deliver on “the promise” of minimizing physician workload and burnout, according to a speaker at the Ending Clinician Burnout Global Community summit.
FDA clears cyber device, AI system to address glioblastoma
An Alabama-based company announced that the FDA has granted 510(k) clearance to its cyber device and AI system, which are designed to improve efficiency and accuracy of glioblastoma care.
Point-of-care AI ultrasound system for diagnosis of cardiac pathologies nets FDA clearance
AISAP announced the FDA granted 510(k) clearance for its first-in-class, AI-powered point-of-care ultrasound software platform for the measurement of several cardiac pathologies.
Icare Finland Oy acquires Thirona Retina
Icare Finland Oy, a subsidiary of Revenio Group, has signed an agreement to acquire the AI software company Thirona Retina, according to a press release.